World Organisation for Animal Health

Font size:

Language :

Search:

Advanced search

Home > For the media

Rinderpest Portal

Global freedom     What is rinderpest?     Eradication programmes     Post-eradication phase   International collaboration     Media resources

Post eradication phase

With the infection eradicated both from livestock and wildlife, the OIE moves on to a post-eradication era with new challenges lying ahead.

Maintaining global freedom from rinderpest

Although the rinderpest virus no longer circulates amongst live animals, virus stocks, vaccines and biologic samples are still present in around 20 laboratories across the world, mainly for the production of vaccines in the event the disease were to reappear due to an accident or an act of bioterrorism.

Until these potential sources of rinderpest virus are either safely destroyed or transferred to one of the high –containment facilities, approved by OIE and FAO, the world remains at risk of a reoccurrence of rinderpest.

Global commitment from Member Countries

All 180 OIE Member Countries signed up to a Resolution at the OIE General Session in May 2011, committing themselves to destroy remaining virus or safely store them in a minimum number of approved high containment laboratories; to remain vigilant to reoccurrences of the disease; and to cease all unapproved research activities. A parallel resolution was adopted by FAO in June 2011. The OIE and FAO are working to ensure that these actions are urgently and fully implemented to prevent this dreadful disease from resurfacing.

The OIE, in collaboration with the FAO and with Member Countries, is committed to ensuring that the process is carried out in a reliable and transparent manner.

Designation of facilities as approved for holding rinderpest virus containing material

In May 2015 at the OIE General Session, the OIE World Assembly of Delegates adopted a resolution to designate the following facilities as approved for holding rinderpest virus containing material (subject to re-evaluation every 3 years). 

A) Rinderpest Holding Facility for storing rinderpest virus containing material, excluding vaccine stocks

  1. African Union Pan African Veterinary Vaccine Centre (AU-PANVAC), Debre-Zeit, Ethiopia.
  2. High Containment Facilities of Exotic Diseases Research Station, National Institute of Animal Health, Kodaira, Tokyo, Japan.
  3. USDA-APHIS, Foreign Animal Disease Diagnostic Laboratory (FADDL), Plum Island, New York, United States of America.
  4. The Pirbright Institute, United Kingdom.

B) Rinderpest Vaccine Holding Facility for storing only manufactured vaccines, vaccine stocks and material solely for their production:

  1. Pan African Veterinary Vaccine Centre African Union (AU-PANVAC), Debre-Zeit, Ethiopia
  2. Building for Safety Evaluation Research, Production Center for Biologicals; Building for Biologics Research and Development (storage), National Institute of Animal Health, Tsukuba, Ibaraki, Japan.

OIE Resolutions

adopted during OIE General Sessions (GS)

  • Derogation allowing the regulated movement of attenuated vaccine seed stock out of a BSL3 facility to an FAO-OIE approved facility (Amendment to resolution 18)


Global freedom     What is rinderpest?     Eradication programmes     Post-eradication phase      International collaboration     Media resources

Top